Opiant Pharmaceuticals to Report Fourth Quarter 2020 Financial Results and Host Conference Call and Webcast on March 4, 2021

Rhea-AI Summary

Opiant Pharmaceuticals (NASDAQ: OPNT) will report its financial results for Q4 and the full year ended December 31, 2020, on March 4, 2021, post-market. A conference call is scheduled for the same day at 4:30 p.m. ET, where management will discuss these results. Investors can access the call via phone or webcast on the company’s website. Opiant is known for its development of medications addressing addictions and drug overdose, including the NARCAN® Nasal Spray.

Positive

• Scheduled financial results announcement for Q4 and year-end 2020.
• Management conference call for investor engagement.

Negative

• None.

SANTA MONICA, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the fourth quarter and year ended December 31, 2020, after the financial markets close on Thursday March 4, 2021.  

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday March 4, 2021. To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13715395. To access the live webcast, please go to the investors section of Opiant’s website at http://ir.opiant.com/. Following the live webcast, an archived version of the call will be available on the website.

Thursday March 4 @ 4:30 pm ET
Domestic:	877-407-0792
International:	201-689-8263
Conference ID:	13715395
Webcast:	http://ir.opiant.com/

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

For more information visit: www.opiant.com.

Investor Relations Contacts:
Ben Atkins
VP of Corporate Communications and Investor Relations
batkins@opiant.com
(310) 598-5410

FAQ

When will Opiant Pharmaceuticals announce its Q4 2020 financial results?

Opiant Pharmaceuticals will announce its Q4 2020 financial results on March 4, 2021.

What time is the conference call for Opiant's Q4 financial results?

The conference call for Opiant's Q4 financial results is scheduled for March 4, 2021, at 4:30 p.m. ET.

How can I access Opiant Pharmaceuticals' financial results webcast?

You can access Opiant Pharmaceuticals' financial results webcast on their investors' section of the website.

What is Opiant Pharmaceuticals known for?

Opiant Pharmaceuticals is known for developing medications for addictions and drug overdose, including the NARCAN® Nasal Spray.